Oxford Biomedica/£OXB

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Oxford Biomedica

Ticker

£OXB
Sector

Primary listing

LSE

Employees

900

Oxford Biomedica Metrics

BasicAdvanced
£739M
-
-£0.36
0.95
-

What the Analysts think about Oxford Biomedica

Analyst ratings (Buy, Hold, Sell) for Oxford Biomedica stock.

Bulls say / Bears say

Oxford Biomedica posted 44% full-year 2024 revenue growth to £128.8 million (organic growth 81%) and recorded an operating EBITDA profit of £5.0 million in H2 2024, marking a pivot to mid-year profitability. (LSE RNS)
In H1 2025, the company generated revenues of £73.2 million (up 44% year-on-year), secured £149 million in contracted client orders, expanded its revenue backlog to £222 million, and narrowed its operating EBITDA loss to £8.3 million. (Sharecast)
After H1, Oxford Biomedica strengthened its balance sheet by securing a four-year loan facility of up to $125 million and raising around £60 million via a share placing, supporting expansion of its global manufacturing, particularly in the U.S. (GuruFocus)
Despite strong revenue momentum, Oxford Biomedica expects only a low single-digit million pounds of operating EBITDA profit for the full year 2025, highlighting limited near-term earnings upside. (Sharecast)
Although sales are rising, the group posted an operating EBITDA loss of £15.3 million for full-year 2024, underscoring ongoing profitability challenges. (LSE RNS)
Oxford Biomedica had an operating cash outflow of £4.8 million in H1 2025, indicating continuing cash burn and funding needs even as revenue improves. (GuruFocus)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

Oxford Biomedica Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Oxford Biomedica Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £OXB

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs
Buy Oxford Biomedica stock | £OXB Share Price | Lightyear